Search results
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 1 day agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 4 days agoFusion (FUSN) is expected to provide updates regarding the developmental program of its lead...
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
WKRN Nashville· 6 days agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company, along with its partners, will present or publish eight abstracts at the American Society of Clinical Oncology (ASCO) ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoInnovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting PR Newswire SAN FRANCISCO and SUZHOU, China, April 24, 2024 SAN FRANCISCO and SUZHOU, China, April 24, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 6 days agoThe NDA is supported by results from JUPITER-02, a randomized, double...
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation...
Digital Journal· 6 days agoThe primary objectives of the trial include determining the maximum tolerated dose and/or recommended Phase 2 dose and evaluating antitumor activity of tulmimetostat monotherapy. The...
The Top 3 Biotech Stocks to Buy in April 2024
InvestorPlace· 3 days agoBiotech stocks are notorious for being some of the most volatile and unpredictable on the market. With clinical trials and FDA approvals creating...
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Morningstar· 6 days agoGlobal licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study ...
Artificial Sweetener Now Classified as ‘Possible Carcinogen'
Mercola· 7 days agoThe artificial sweetener aspartame is primarily made up of aspartic acid and phenylalanine. The phenylalanine has been synthetically modified to carry a methyl group, which provides most of ...
HOOKIPA advances HPV cancer trial with FDA nod By Investing.com
Investing.com· 5 days ago(NASDAQ: HOOK), a clinical-stage biopharmaceutical company, has announced the final design for its...